We are live on ! Find out more
HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP

Delisted

HZNP was delisted on the 5th of October, 2023.

Back to rankings

59 hedge funds and large institutions have $77.9M invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2013 Q2 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,459% more call options, than puts

Call options by funds: $2.51M | Put options by funds: $161K

Holders
59
Holders Change
+59
Holders Change %
–
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
59
Increased
–
Reduced
–
Closed
–
Calls
$2.51M
Puts
$161K
Net Calls
+$2.35M
Net Calls Change
+$2.35M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

HZNP Hedge Fund Activity: Q2 2013 in Review

59 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q2 2013, worth a combined $77.9M.

Buyers outnumbered sellers: 59 funds opened new HZNP positions and 0 closed out — a net gain of 59 holders — while 0 added to existing stakes and 0 trimmed.

  • 59 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $77.9M of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q2 2013.
  • 59 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q2 2013 and 0 closed out, a net change of +59 holders.

Based on aggregated 13F filings for Q2 2013.